Abbott Vascular reportedly lays off 100 workers at a plant in Temecula, Calif.
Abbott Vascular (NYSE:ABT) is laying off about 100 workers at a California plant it acquired when it bought a portion of Guidant Corp. in 2006.
Smith & Nephew is reportedly shuttering a wound management unit in St. Petersburg, Fla., meaning layoffs for the 108 workers there.
BD has acquired GenCell Biosystems, an Irish startup with a system to automate the creation of "libraries" that help scientists sequence gene information, while reportedly cutting jobs in California.
Teleflex reportedly plans an expansion of its catheter production operations in the Czech Republic.
Teleflex (NYSE:TFX) reportedly plans to expand its catheter production operations in the Czech Republic, where it already has some 700 employees.
Abbott Vascular plans to shutter a plant in Texas that makes its Supera peripheral stents as it shifts production and 50 jobs to another plant in California.
California-based Allergan informs state regulators that it plans to permanently lay off 129 employees.
Embattled aesthetic devices maker Allergan (NYSE:AGN) informed California state authorities that it plans to cut 129 workers over the next few weeks.
Massachusetts-based Accellent announces plans to close plants in Colorado and Ireland as the company integrates with Lake Region Medical.
Accellent is preparing to close doors on a couple manufacturing facilities as the device maker navigates its integration with Lake Region Medical Center.
Accellent said that it will close down a plant in Arvada, Colo., resulting in layoffs for some 200 workers. The company is also planning to consolidate a pair of Galway, Ireland, facilities into a single location, but hopes to keep most of those employees.